We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Gilead Sciences Ltd

Gilead Medical Information (UK & Eire), 280 High Holborn, London, WC1V 7EE, UK
Telephone: +44 (0)203 681 4500
E-mail: Prod complaints: UKIEproductcomplaints@gilead.com
Medical Information Direct Line: +353 214 825 999
Medical Information Direct Line: 08000 113 700 (UK)
Medical Information e-mail: ukmedinfo@gilead.com
Customer Care direct line: +44 (0)203 681 4681
Patient Information Leaflet last updated on medicines.ie: 2/13/2018
PIL Truvada film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 2/13/2018 and displayed until Current
Reasons for adding or updating:
  • Change to section 3 - use in children/adolescents
  • Change to section 6 - date of revision
  • Change to section 1 - what the product is used for
  • Change to section 3 - dose and frequency
Updated on 7/5/2017 and displayed until 2/13/2018
Reasons for adding or updating:
  • Change to section 6 - date of revision
  • Change to other sources of information section
Updated on 6/6/2017 and displayed until 7/5/2017
Reasons for adding or updating:
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision
Updated on 4/3/2017 and displayed until 6/6/2017
Reasons for adding or updating:
  • Change to section 1 - what the product is used for
  • Change to section 2 - use in children and adolescents
  • Change to section 3 - use in children/adolescents
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Updated on 8/26/2016 and displayed until 4/3/2017
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to instructions about missed dose
  • Change to instructions about overdose
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to how the medicine works
  • Change to date of revision
  • Change to MA holder contact details
Updated on 5/13/2016 and displayed until 8/26/2016
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
  • Change to MA holder contact details
Updated on 2/12/2016 and displayed until 5/13/2016
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 6/22/2015 and displayed until 2/12/2016
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 3/13/2015 and displayed until 6/22/2015
Reasons for adding or updating:
  • Change to date of revision
  • Change to name of manufacturer
Updated on 1/28/2015 and displayed until 3/13/2015
Reasons for adding or updating:
  • Change to date of revision
  • Introduction of new pack/pack size
Updated on 8/28/2014 and displayed until 1/28/2015
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 4/2/2014 and displayed until 8/28/2014
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to date of revision
Updated on 3/5/2014 and displayed until 4/2/2014
Reasons for adding or updating:
  • Change to date of revision
  • Change to MA holder contact details
Updated on 6/21/2013 and displayed until 3/5/2014
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 3/5/2013 and displayed until 6/21/2013
Reasons for adding or updating:
  • Change to date of revision
Updated on 8/16/2011 and displayed until 3/5/2013
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
  • Change to further information section
  • Change to date of revision
  • Changes to therapeutic indications
Updated on 6/10/2011 and displayed until 8/16/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to name of manufacturer
Updated on 12/7/2010 and displayed until 6/10/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 9/15/2010 and displayed until 12/7/2010
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 2/3/2010 and displayed until 9/15/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change due to harmonisation of patient information leaflet
Updated on 1/30/2009 and displayed until 2/3/2010
Reasons for adding or updating:
  • Addition of marketing authorisation holder
Updated on 7/7/2008 and displayed until 1/30/2009
Reasons for adding or updating:
  • Introduction of new pack/pack size
Updated on 6/18/2007 and displayed until 7/7/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 5/17/2007 and displayed until 6/18/2007
Reasons for adding or updating:
  • Change to side-effects
  • Addition of marketing authorisation holder
Updated on 9/27/2006 and displayed until 5/17/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 4/15/2005 and displayed until 9/27/2006
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Tenofovir disoproxil fumarate
   Emtricitabine